STAT February 16, 2025
Lizzy Lawrence

The office has a strained relationship with Musk’s company Neuralink

WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to have hit the AI and digital health staff particularly hard at a time when federal regulators are scrambling for ways to keep tabs on hospitals and insurers that are embracing the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Congress / White House, FDA, Govt Agencies, Technology
Device industry scrambles as FDA job cuts cause delays
FDA approves first rapid-acting insulin biosimilar for diabetes
Device industry scrambles amid concern FDA layoffs will cause delays
First Insulin Aspart Biosimilar Receives FDA Approval
In FDA job cuts, experts see threat of far-reaching impact

Share This Article